Loading…
for educational and safety purposes
sci-wiki~$open stack cannabis-recovery
eleven items aimed at the weeks after heavy cannabis use, and one finding that changes how you should read all of them
11 items; 9 structures drawn from pubchem, 2 drawn generically because pubchem has no record of the name.
This roster is aimed at a real problem. Heavy cannabis use does measurable things: CB1 receptors downregulate, adolescent exposure prunes dendritic spines in the prefrontal cortex in rats, and the fog people describe after stopping is not imaginary.
The items here were chosen against a mechanistic story, and the honest thing to say is that most of that story is thinner than it sounds. Every claim behind this stack was checked against the primary literature, and the pattern is consistent: a real finding in a rodent or a dish, then a confident leap to cannabis recovery that nobody has tested. NAC is the exception worth knowing about, and even it is split; it beat placebo for cannabis abstinence in adolescents and did nothing at all in a 302-person, six-site adult trial. That is not a reason to skip the stack. It is the reason each item above says what it actually rests on, so the decision is yours rather than the copy's.
What the roster does well is spread its bets across mechanisms that do not overlap: glutamate, cAMP, AMPA, membranes, mitochondria and neurotrophic support. If any of them matters, they are unlikely to all fail for the same reason.
The layers do different jobs and mostly do not collide.
NAC and NACET are the same intervention and should not be run together; NACET is a more cell-permeant ester of NAC, so taking both is one mechanism at an unknown total. The same applies to cerebrolysin and cortexin, which are two porcine-brain peptide preparations aimed at the same idea.
BPN14770 and TAK-653 sit either side of one synapse: the PDE4 inhibitor keeps cAMP signalling up, and the AMPA potentiator raises what an existing glutamate release actually does. Neither creates activity on its own, which is the argument for pairing them rather than adding a stimulant.
Piracetam, fish oil and acetyl-L-carnitine are the metabolic floor, and they are the items with the longest safety record and the least dramatic claims. Tropisetron sits slightly apart: it is here for a CB1 result rather than for its own well-established alpha-7 activity, which is worth knowing when judging whether to keep it.
Reports from people running something like this describe the first two to three weeks as the hard part: sleep is broken, appetite is odd, and irritability is the symptom most people underestimate. Anything this stack does arrives against that background, which makes attribution genuinely difficult; the same fortnight would improve on its own.
The items with a same-day feel are the AMPA and PDE4 arms. Piracetam, fish oil and the carnitine are cumulative and unremarkable to take.
⚠️ MOST OF THIS RECOVERS ON ITS OWN, AND THAT IS THE MOST USEFUL FACT ON THIS PAGE. Human PET imaging found that cortical CB1 receptor density in chronic daily cannabis smokers returned to normal levels after roughly four weeks of monitored abstinence, with no intervention at all (PMID 21747398). Any stack sold as restoring CB1 signalling is competing with something that largely fixes itself in a month. Judge these items on what they add over simply stopping, and give it four weeks before concluding anything. ⚠️ CEREBROLYSIN AND CORTEXIN HAVE NO CANNABIS EVIDENCE IN ANY SPECIES. A 2025 scoping review that specifically searched cerebrolysin in addiction across three databases concluded the application in psychiatry is small. They are parenteral products; the intranasal route sometimes suggested for them has no pharmacokinetic or efficacy data behind it. ⚠️ PREGNENOLONE IS CONTESTED RATHER THAN ESTABLISHED. The 2014 result that made it interesting failed to replicate in three independent laboratories, and there is a further concern worth stating: sustained CB1 blockade is the mechanism that got rimonabant withdrawn worldwide for depression and suicidality. BPN14770 and TAK-653 are investigational; neither is approved anywhere, and neither has been given to a cannabis user in a trial. Acetyl-L-carnitine's own source paper reported that it produced a sensitised behavioural response on its own in rats, which is the opposite of what a recovery agent is supposed to do. NAC affects glutamate signalling and is the item most likely to interact with psychiatric medication. If cannabis use is heavy and daily, stopping abruptly is where the discomfort lives, and none of this replaces talking to a doctor about that.
nothing flaggedcurated roster
every pair here reads as compatible on the mechanisms the site holds. that is the absence of a known conflict, not a clearance.
5 of 11 in one basketKimera Chems; Code Sean
Fish Oil has no outlet here at all.
9 of 11 priced
2 of these carry no listed price, so there is no honest total to print; the lines above are what can actually be costed.
2 overlapssame lever, twice
interested in protocols? join the discord; that is where dosing, timing and the practical side get discussed.
the sci-wiki publishes this as a description of what these compounds do together, not as a recommendation to take them. Nothing here is medical advice.